ReachMD Profile Banner
ReachMD Profile
ReachMD

@ReachMD

Followers
3K
Following
4K
Media
9K
Statuses
16K

Your single destination for free CMEs, medical news, & more. Be Part of the Knowledge.

Joined September 2008
Don't wanna be here? Send us removal request.
@ReachMD
ReachMD
19 hours
Tomorrow’s the day! Join us at the Otsuka booth #1503 during ASN Kidney Week 2025 for a discussion with Dr. Edgar Lerma and Dr. Luis Vélez on the role of APRIL and the 4-Hit Process in the pathogenesis of IgA Nephropathy.
0
0
1
@ReachMD
ReachMD
2 days
Drs. Tesar and @MegSise unpack why today’s FSGS therapies often fall short and what’s needed next. Keep watching the full discussion here: https://t.co/1VuRN8LZgZ #Nephrology #FSGS #CME #KidneyCare
0
0
1
@ReachMD
ReachMD
2 days
Tomorrow: MOD Live 2025 at Austin Marriott Downtown. In-person CE, expert panels, and case-based insights across glaucoma, OSD, presbyopia, retina, and more. Last chance to enroll: https://t.co/ArmUP56s9F  #Optometry #CE #Austin #MedicalOptometry
Tweet card summary image
reachmd.com
Welcome to MOD Live 2025! Join us and be a part of redefining the boundaries in optometry. We're taking clinical education a step further with 8.75 hours of FREE CE, expert panels, collaborative...
0
0
1
@ReachMD
ReachMD
8 days
1 week to go! Join us at the Otsuka booth #1503 during ASN Kidney Week 2025 with Dr. Edgar Lerma and Dr. Luis Vélez where they discuss the role of APRIL and the 4-Hit Process in the pathogenesis of IgA Nephropathy. #IgAN
0
0
0
@ReachMD
ReachMD
8 days
Heading to Austin? Join program chairs Selina McGee, Justin Schweitzer, and Walter Whitley with keynotes Carlo Pelino and Osama Said. Free CE for optometrists. Register: https://t.co/f5XbnkLzwq  #Optometry #CE #InPerson #Glaucoma #DryEye
Tweet card summary image
reachmd.com
Welcome to MOD Live 2025! Join us and be a part of redefining the boundaries in optometry. We're taking clinical education a step further with 8.75 hours of FREE CE, expert panels, collaborative...
0
0
0
@ReachMD
ReachMD
9 days
Happening today! Get live insights on FcRn therapies in gMG at AANEM 2025—covering trial data, special populations, and more. Register for the virtual broadcast: https://t.co/dbhmFWMcNt Sign up for an in-person seat: https://t.co/oJXTkSIa3l #AANEM2025 #Neurology #LiveEvent
Tweet card summary image
reachmd.com
This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the management of generalized myasthenia gravis. Faculty...
0
0
0
@ReachMD
ReachMD
9 days
Dr. Lieberman explains how treatment burden impacts care, and how emerging options can help you personalize your approach: https://t.co/HEPsskYLYx #FSGS #Nephrology #CME #Proteinuria
0
0
0
@ReachMD
ReachMD
10 days
Tomorrow at AANEM: Your guide to FcRn therapies in gMG. Join expert faculty for a focused session on clinical application and key treatment considerations. Reserve your spot to stream live: https://t.co/T0dYhsK7mo Be there in person: https://t.co/iElMoGub4C #AANEM2025
Tweet card summary image
reachmd.com
This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the management of generalized myasthenia gravis. Faculty...
0
0
0
@ReachMD
ReachMD
13 days
FcRn antagonists are reshaping gMG treatment. Get expert insight into mechanisms, trial data, and therapeutic decision-making at AANEM 2025—either at the event or on the live broadcast. Register to attend virtually: https://t.co/2I4oV4H7lH Join in person:
Tweet card summary image
reachmd.com
This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the management of generalized myasthenia gravis. Faculty...
0
0
0
@ReachMD
ReachMD
15 days
How do antibody profiles shape FcRn therapy in gMG? Find out with this expert-led symposium at AANEM 2025, available live on-site or via livestream. Sign up for online access: https://t.co/2I4oV4H7lH Attend in person at AANEM: https://t.co/PN8515e2IX #AANEM2025 #Neurology
Tweet card summary image
reachmd.com
This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the management of generalized myasthenia gravis. Faculty...
0
0
0
@ReachMD
ReachMD
15 days
ASN Kidney Week 2025: Join Dr. Luis Vélez & Dr. Edgar Lerma in the Otsuka booth #1503 for a discussion about the role of APRIL and the 4-Hit Process in the pathogenesis of IgA Nephropathy. #IgAN
0
0
0
@ReachMD
ReachMD
16 days
FSGS 360 explores current and emerging treatments, patient-reported outcomes, and strategies for optimizing care in both adults and children. Hear from experts now: https://t.co/WWkhRCccXR #Nephrology #FSGS #CME @MegSise
Tweet card summary image
reachmd.com
Managing patients with focal segmental glomerulosclerosis, or FSGS, can present certain challenges. FSGS is a serious, progressive condition that has no current FDA-approved treatment and standard of...
0
0
0
@ReachMD
ReachMD
21 days
FSGS isn’t one-size-fits-all. This quick CME breaks down how to tailor diagnosis and treatment based on patient needs—and why outcomes depend on more than just proteinuria: https://t.co/nXxhBYsSOk #FSGS #Nephrology #CME #KidneyHealth #PatientCare
Tweet card summary image
reachmd.com
Focal segmental glomerulosclerosis (FSGS) is a prominent cause of kidney failure globally, necessitating dialysis for patient survival as the disease progresses. However, the current absence of...
0
0
0
@ReachMD
ReachMD
22 days
Managing FSGS? This CME explores patient-centered strategies for diagnosis, treatment, and evaluating emerging therapies in adult and pediatric patients. Start now: https://t.co/DLHFhI1Xaq #FSGS #Nephrology #CME #KidneyHealth #Proteinuria
0
0
0
@ReachMD
ReachMD
23 days
The showdown is TOMORROW! KOL KNOCKOUT™: Oculoplastics Edition brings TED experts to the ring for high-energy case debates. Last chance to register for this CME symposium! In person: https://t.co/alqEqz5iaw Online: https://t.co/fOISD3VvBE #TEDmanagement #Oculoplastics #CME
0
0
0
@ReachMD
ReachMD
24 days
“Look beyond the labs. See the whole patient.” Dr. Trachtman explains how patient-centered decision-making changes outcomes in FSGS: https://t.co/vsLope46J0 #FSGS #Nephrology #CME
1
0
1
@ReachMD
ReachMD
29 days
Fierce debate. Expert pearls. Can’t-miss TED strategies. KOL KNOCKOUT™: Oculoplastics Edition is in just one week. Come to the in-person event: https://t.co/alqEqz5iaw Check out the broadcast: https://t.co/fOISD3VvBE #ThyroidEyeDisease #Ophthalmology #CME
0
0
1